Ventripoint Diagnostics Stock Price on September 20, 2024
| VPT Stock | CAD 0.10 0.01 11.11% |
Below is the normalized historical share price chart for VentriPoint Diagnostics extending back to August 24, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of VentriPoint Diagnostics stands at 0.10, as last reported on the 18th of December 2024, with the highest price reaching 0.11 and the lowest price hitting 0.1 during the day.
If you're considering investing in VentriPoint Stock, it is important to understand the factors that can impact its price. VentriPoint Diagnostics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0979, which indicates the firm had a -0.0979% return per unit of risk over the last 3 months. VentriPoint Diagnostics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VentriPoint Diagnostics' Risk Adjusted Performance of (0.07), variance of 39.43, and Coefficient Of Variation of (1,037) to confirm the risk estimate we provide.
At this time, VentriPoint Diagnostics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to climb to about 164.7 M in 2024, whereas Common Stock is likely to drop slightly above 28.8 M in 2024. . At this time, VentriPoint Diagnostics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to climb to 256.06 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (12.77) in 2024. VentriPoint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.1929 | 50 Day MA 0.1378 | Beta 0.388 |
VentriPoint |
Sharpe Ratio = -0.0979
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VPT |
Estimated Market Risk
| 6.38 actual daily | 56 56% of assets are less volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average VentriPoint Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VentriPoint Diagnostics by adding VentriPoint Diagnostics to a well-diversified portfolio.
Price Book 7.1297 | Enterprise Value Ebitda (6.68) | Price Sales 199.3982 | Shares Float 156.4 M | Earnings Share (0.03) |
VentriPoint Diagnostics Main Headline on 20th of September 2024
Ventripoint Completes First Tranche of Private Placement - T... by news.google.com
Ventripoint Completes First Tranche of Private Placement TipRanks
VentriPoint Diagnostics Valuation on September 20, 2024
It is possible to determine the worth of VentriPoint Diagnostics on a given historical date. On September 20, 2024 VentriPoint was worth 0.17 at the beginning of the trading date compared to the closed value of 0.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of VentriPoint Diagnostics stock. Still, in general, we apply an absolute valuation method to find VentriPoint Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of VentriPoint Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against VentriPoint Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 0.17 | 0.17 | 0.17 | 0.17 | 153,000 | |
09/20/2024 | 0.17 | 0.17 | 0.17 | 0.17 | 82,475 |
| 0.18 | 0.18 | 0.18 | 0.18 | 17,000 |
| Backtest VentriPoint Diagnostics | | | VentriPoint Diagnostics History | | | VentriPoint Diagnostics Valuation | Previous | Next |
VentriPoint Diagnostics Trading Date Momentum on September 20, 2024
| On September 23 2024 VentriPoint Diagnostics was traded for 0.18 at the closing time. The highest daily price throughout the period was 0.18 and the lowest price was 0.18 . The daily volume was 17 K. The net trading volume on 09/23/2024 added to the next day price increase. The trading price change to closing price of the next trading day was 5.88% . The trading price change to current closing price is 0.00% . |
VentriPoint Diagnostics Fundamentals Correlations and Trends
By evaluating VentriPoint Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among VentriPoint Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. VentriPoint financial account trend analysis is a perfect complement when working with valuation or volatility modules.About VentriPoint Diagnostics Stock history
VentriPoint Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for VentriPoint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in VentriPoint Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing VentriPoint Diagnostics stock prices may prove useful in developing a viable investing in VentriPoint Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 156.8 M | 164.7 M | |
| Net Loss | -2.1 M | -2.2 M |
VentriPoint Diagnostics Stock Technical Analysis
VentriPoint Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
VentriPoint Diagnostics Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
VentriPoint Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on TSX Venture Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
VentriPoint Diagnostics December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how VentriPoint Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VentriPoint Diagnostics shares will generate the highest return on investment. By undertsting and applying VentriPoint Diagnostics stock market strength indicators, traders can identify VentriPoint Diagnostics entry and exit signals to maximize returns
VentriPoint Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for VentriPoint Diagnostics' price direction in advance. Along with the technical and fundamental analysis of VentriPoint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of VentriPoint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.4356 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.